Considering the amazing size of Amazon (AMZN) already, it’s hard to imagine that the company will be able to climb much higher, that is, until you take a look at what the company has in the works. You see, Amazon has three big things in the works right now that will likely send the stock…
In January of this year, I finally gave up on the near-term prospects of the iShares Nasdaq Biotechnology ETF (IBB) reversing what I called “The Clinton Bash.” After a rapid cascade downward from The Clinton Bash, IBB made three attempts from November to December, 2015 to reverse those losses. Those attempts came to a crashing…
If there’s a trillion bucks AGAINST the rally, then imagine how much money is PUSHING the rally for it to continue. Now, where would this kind of money come from? It ain’t you and I, that’s for sure – pardon the very bad grammar! It is becoming pretty obvious that the big money wants to…
My younger daughter doesn’t conform to, well, much of anything. As a very young girl, she insisted on doing her own hair. She liked pony tails – lots of them – but as a four or five-year-old, she didn’t have much skill at getting them right. This meant that she often had 11 or 12…
This Great Graphic shows the results of the last three Wall Street Journal survey of business and academic economists on the outlook for Fed policy. The key take away is that despite all the talk and ink spilled on the shifting Fed stance and the split within the FOMC, economists views did not change much…
It’s as though I know what I’m talking about… Several months ago when I was speaking at our Total Wealth Symposium in The Bahamas, I laid out a simple, straightforward path that would see China devalue its currency which would, in turn, lead to the Federal Reserve finally finding the cover it needs to raise interest rates…
As of this moment, various European banks but most prominently Deutsche Bank… … as well as Credit Suisse and RBS, have been crashing back to lows hit in early February and then all the way back to the March 2009 “the world is ending” lows.We commented on this yesterday using, ironically enough, a note by…
Valeant Pharmaceuticals Intl Inc. (VRX) obtained consent from over half of loan holders to push back regulatory filing deadlines and loosen financial conditions on the loans. The week marks a series of positive developments for the struggling drug maker and, mirroring the positive developments, Valeant shares surged $5.44, or 19% Wednesday to close at $34.17, making the latest increase…
The trend is obvious for anyone who has eyes to see it.
Once again, the Japanese Yen and the US Dollar have taken control of the spotlight in the FX market. The safe haven Yen continues to be the currency of choice for investors uncertain of the future of the global economy. Meanwhile the Dollar is getting hammered from all sides on expectations of any rate hike…
